Company Overview - ZimVie Inc. is a global leader in the dental market, focusing on life sciences and offering a comprehensive portfolio of products for dental tooth replacement and restoration procedures [2] - The company is headquartered in Palm Beach Gardens, Florida, and operates additional facilities worldwide [2] - ZimVie aims to enhance smiles, function, and confidence through its dental implants, biomaterials, and digital workflow solutions [2] Upcoming Events - ZimVie management will participate in the Stifel 2025 Jaws & Paws Conference, scheduled for May 28, 2025, at 3:00 p.m. Eastern Time [1] - A live webcast and archived recording of the event will be available on ZimVie's investor website [1]

Core Viewpoint - ZimVie Inc. reported a net sales decrease of 5.2% for Q1 2025, but showed significant improvement in net loss and adjusted net income compared to the same period in 2024, indicating a focus on operational efficiency and profitability improvements [2][3][4]. Financial Performance - Net sales for Q1 2025 were $112.0 million, down 5.2% from Q1 2024, with a constant currency decrease of 4.1% [2][28]. - The net loss for Q1 2025 was $(2.6) million, an improvement of $8.9 million from a net loss of $(11.5) million in Q1 2024, resulting in a net loss margin of (2.3%), up 740 basis points from (9.7)% in Q1 2024 [3][4]. - Adjusted net income for Q1 2025 was $7.4 million, an increase of $5.2 million compared to Q1 2024 [3][4]. Earnings Per Share - Basic and diluted EPS for Q1 2025 were $(0.09), while adjusted diluted EPS was $0.27 [4][29]. Adjusted EBITDA - Adjusted EBITDA for Q1 2025 was $17.6 million, representing 15.7% of net sales, an increase of $5.1 million or 520 basis points from Q1 2024 [4][35]. Full Year Guidance - For the full year 2025, ZimVie projects net sales between $445 million and $460 million, adjusted EBITDA between $65 million and $70 million, and adjusted EPS between $0.80 and $0.95 [5]. Operational Focus - The company emphasizes a strong focus on execution and operational diligence to maintain its leading position in the dental market through innovation and education [2][8].

Company Overview - ZimVie Inc. is a global leader in the dental market, focusing on life sciences and offering a comprehensive portfolio of products for dental tooth replacement and restoration procedures [2][3] - The company is headquartered in Palm Beach Gardens, Florida, and operates additional facilities worldwide [2] Financial Results Announcement - ZimVie will report its financial results for the first quarter of 2025 after market close on May 8, 2025 [1] - A conference call will be hosted by company management at 4:30 p.m. Eastern Time on the same day [1] Conference Call Details - Interested participants can register online to listen to the conference call, with a recommendation to register more than 15 minutes before the start [2] - A replay of the webcast will be available on the investor section of ZimVie's website [2]

Core Insights - Solventum Corporation (SOLV) has partnered with SprintRay to introduce a revolutionary solution for digital dentistry, enabling high-quality, same-day dental restorations through advanced 3D printing technology [1][3] - This collaboration aims to enhance dental care by reducing turnaround time and improving the quality of restorations, providing dental professionals with reliable and cost-effective treatment options [2][4] Company Developments - The partnership introduces the first permanent, chairside 3D-printed crown, combining Solventum's expertise in advanced dental materials with SprintRay's 3D printing technology [3] - The initiative focuses on enhancing patient experience and clinical efficiency by minimizing chair time, reducing office visits, and lowering treatment costs [4][5] Industry Prospects - The global digital dentistry market was valued at $6 billion in 2024 and is projected to reach approximately $19.66 billion by 2034, with a CAGR of 12.6% from 2024 to 2034 [6] - Market growth is driven by the return on investment from digital dentistry equipment, efficiency of same-day procedures, and increasing demand for aesthetic treatments [7] Competitive Landscape - Align Technology, Inc. (ALGN) is enhancing its product offerings in orthodontics and dentistry, including new capabilities for its iTero Lumina intraoral scanner [8] - Dentsply Sirona (XRAY) is driving innovation with product developments like the Primescan 2 intraoral scanner and enhancements to the DS Core platform [10][11] - Envista Corporation (NVST) is advancing digital dentistry with new offerings from DEXIS, including a new CBCT platform and the DEXIS Ti2 Sensor [12][13]

Company Overview - ZimVie Inc. is a global leader in the dental market, focusing on life sciences and providing a comprehensive portfolio of products for dental tooth replacement and restoration procedures [2] - The company is headquartered in Palm Beach Gardens, Florida, and operates additional facilities worldwide [2] - ZimVie aims to enhance smiles, function, and confidence through its offerings, which include dental implants, biomaterials, and digital workflow solutions [2] Upcoming Events - ZimVie management will participate in the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025, at 3:00 p.m. Eastern Time [1] - A live webcast and archived recording of the event will be available on ZimVie's investor website [1]

Core Insights - ZimVie Inc. reported a transformational year in 2024, becoming a pure play dental company and reducing net debt by over $290 million [2] - The company achieved an increase in Adjusted EBITDA margins by over 4 percentage points in Q4 2024 compared to Q4 2023, despite a softer end market [2] - ZimVie is optimistic about the long-term growth drivers in the dental implant market, supported by successful training and education programs [2] Financial Performance - Q4 2024 - Third-party net sales for Q4 2024 were $111.5 million, a decrease of 1.4% on a reported basis and 0.9% in constant currency compared to Q4 2023 [3] - The net loss for Q4 2024 was $(9.7) million, an improvement of $12.5 million from a net loss of $(22.2) million in Q4 2023 [4] - Adjusted net income for Q4 2024 was $7.6 million, an increase of $5.0 million from Q4 2023 [4] Financial Performance - Full Year 2024 - Total third-party net sales for the full year 2024 were $449.7 million, a decrease of 1.6% on a reported basis and 1.2% in constant currency compared to 2023 [6] - The net loss for the full year 2024 was $(33.8) million, an improvement of $22.2 million from a net loss of $(56.0) million in 2023 [7] - Adjusted EBITDA for the full year 2024 was $60.0 million, or 13.3% of third-party net sales, an increase of $9.2 million from 2023 [8] Financial Guidance for 2025 - Projected net sales for FY2025 are expected to be between $445 million and $460 million, reflecting a growth of (1%) to 2% [11] - Adjusted EBITDA for FY2025 is projected to be between $65 million and $70 million, indicating an increase of 8% to 17% [11] - Adjusted EPS for FY2025 is expected to be between $0.80 and $0.95, representing a growth of 29% to 53% [11] Company Overview - ZimVie Inc. is a global leader in the dental market, focusing on developing and delivering products for dental tooth replacement and restoration procedures [13] - The company aims to improve smiles and confidence through its comprehensive portfolio, including dental implants and digital workflow solutions [13]